Semaglutide 50mg — Vial Spec, Reconstitution Math & COA

Overview of Semaglutide 50mg Research Vial Specifications

Semaglutide is a long-acting glucagon-like peptide-1 (GLP-1) receptor agonist engineered through recombinant DNA technology or automated solid-phase peptide synthesis (SPPS). Structurally modified from native GLP-1 (7-37), the peptide features an amino acid substitution at position 8 (alanine to alpha-aminoisobutyric acid) to impart resistance against dipeptidyl peptidase-4 (DPP-4) enzymatic cleavage. Additionally, a C18 fatty diacid side chain attached via a glutamic acid spacer at position 26 enables high-affinity non-covalent binding to serum albumin. This structural modification extends the systemic half-life in rodent models from minutes to approximately 96 hours, making it a foundational tool for metabolic and endocrine research.

A 50mg vial represents a specialized mass allocation tailored for high-volume research facilities. Rather than serving single-assay endpoints, a 50mg lyophilized cake provides sufficient active pharmaceutical ingredient (API) equivalent to supply multi-week experimental arms, continuous cell culture media supplementation, or large-scale receptor occupancy studies. Laboratories utilizing 50mg vials require high-precision pipetting protocols and stringent storage controls to maintain peptide integrity across extended testing windows.

Target Research Applications for High-Mass Peptides

High-mass vial configurations like 50mg are predominantly integrated into high-throughput research settings where standard lower-mass vials (such as 2mg, 5mg, or 10mg) would introduce batch-to-batch reconstitution variability. In preclinical rodent models evaluating metabolic kinetics, beta-cell signaling pathways, or central nervous system GLP-1 receptor engagement, large sample sizes demand consistent stock solutions across multi-day dosing schedules.

In vitro research groups exploring receptor internalization, cyclic adenosine monophosphate (cAMP) accumulation, and downstream beta-arrestin recruitment benefit from preparing a standardized 50mg master stock solution. Utilizing a single master lot reduces experimental drift caused by subtle volumetric or reconstitution variances across multiple smaller vials. Furthermore, industrial screening platforms evaluating competitive ligand binding against novel incretin mimetics rely on high-concentration stock formulations to perform broad serial dilution series.

PX1 Research Catalog Availability & Custom Order Workflows

Researchers looking to procure standard laboratory catalog sizes will find that PX1 Research maintains off-the-shelf single-vial formats optimized for standard experimental designs. To review currently stocked mass options, researchers can browse our complete all peptides catalog, which includes standard 2mg, 5mg, and 10mg vial sizes.

While standard catalog inventory emphasizes these versatile, smaller mass allocations to limit peptide waste in short-term studies, PX1 Research regularly fulfills custom high-mass production runs—including 50mg lyophilized vials—for enterprise laboratories, universities, and contract research organizations (CROs). Facilities requiring custom unit fills, bulk peptide mass, or specific vial geometries can submit a requisition through our wholesale portal to coordinate dedicated synthesis runs accompanied by tailored analytical verification.

Precise Reconstitution Math for 50mg Vials

Reconstituting a 50mg mass cake requires careful calculation to achieve target concentrations suitable for micro-pipetting. Because dissolving 50mg of dense lyophilized powder into small liquid volumes can alter final displacement, researchers must calculate concentrations based on added diluent volume while recognizing minor volumetric displacement factor effects.

Common diluent volumes and their resulting working stock concentrations for a 50mg semaglutide vial include:

• 1.0 mL Diluent Addition: Yields a concentration of 50.0 mg/mL (50.0 µg/µL). This hyper-concentrated stock is suitable for master stock storage and high-concentration in vitro screening, but requires high-precision micro-pipettes for dilution.

• 2.0 mL Diluent Addition: Yields a concentration of 25.0 mg/mL (25.0 µg/µL). This concentration balances working solubility with manageable pipetting volumes for secondary stock preparation.

• 3.0 mL Diluent Addition: Yields a concentration of 16.67 mg/mL (16.67 µg/µL). An intermediate concentration frequently used when preparing intermediate working solutions for medium-sized animal cohorts.

• 5.0 mL Diluent Addition: Yields a concentration of 10.0 mg/mL (10.0 µg/µL). This concentration facilitates straightforward volumetric math for routine assays (e.g., 10 µL delivers exactly 100 µg of active peptide).

To verify volumetric math for custom concentration targets or alternative diluent ratios, researchers should utilize the interactive PX1 Research reconstitution calculator tool prior to solvent introduction.

Sub-Aliquot Protocols & Preventing Freeze-Thaw Degradation

Reconstituting a 50mg vial into a single container that is repeatedly accessed exposes the peptide solution to ambient temperature spikes, oxygen introduction, and multiple freeze-thaw cycles. Peptide bonds and side-chain fatty acid modifications are susceptible to hydrolytic cleavage, oxidation (particularly at methionine residues if present), and aggregation when repeatedly frozen and thawed.

To preserve structural integrity, laboratories must implement a sub-aliquoting protocol immediately following primary reconstitution. After introducing sterile bacteriostatic water or target assay buffer (such as PBS, pH 7.4), gently invert or swirl the vial until the cake is completely dissolved; never vortex high-mass peptide solutions, as mechanical shear stress can induce aggregation. Using sterile, low-binding polypropylene microcentrifuge tubes, divide the master reconstituted solution into single-use aliquots (e.g., 50 µL to 200 µL per tube) matching the required daily consumption of the experimental protocol.

Aliquots intended for use within 14 to 28 days should be maintained at 2°C to 8°C if reconstituted with bacteriostatic diluent containing 0.9% benzyl alcohol. Long-term storage of reconstituted aliquots requires rapid freezing at -20°C or -80°C. Individual tubes should be thawed once prior to assay execution and any remaining unused solution discarded to ensure quantitative consistency across all experimental time points.

Analytical Verification: Lot-Matched COA, HPLC, and MS Integrity

High-mass peptide synthesis introduces unique chemical challenges during cleavage, purification, and lyophilization. PX1 Research subjects every synthesis lot to rigid quality control protocols within ISO 17025 accredited analytical laboratories, ensuring that bulk 50mg formats match the structural purity of standard catalog items.

Every batch is verified through High-Performance Liquid Chromatography (HPLC) to confirm peptide purity of ≥99.0%. Purity determination measures the area-under-the-curve (AUC) of the primary semaglutide chromatographic peak relative to potential deletion sequences or truncated synthesis byproducts. Mass Spectrometry (MS) analysis confirms the precise molecular mass (monoisotopic molecular weight ~4113.5 Da), verifying that the fatty acid chain and amino acid sequence match theoretical parameters perfectly.

Furthermore, because high-mass vials are frequently employed in sensitive cell culture or animal models where bacterial contaminants compromise physiological parameters, PX1 conducts Limulus Amebocyte Lysate (LAL) testing on every lot. Endotoxin levels are guaranteed below stringent thresholds (<0.01 EU/µg). Researchers can view or download batch-specific analytical reports directly through our dedicated COA lookup portal.

Comparative Analysis: Semaglutide vs. Multi-Receptor Incretin Mimetics

In preclinical metabolic research, semaglutide serves as the baseline selective GLP-1 receptor agonist. However, comparative studies frequently evaluate its signaling kinetics against emerging dual and triple receptor agonists to delineate single-pathway versus synergistic metabolic cascades.

For instance, researchers evaluating dual incretin activity frequently compare semaglutide against tirzepatide, a dual GIP and GLP-1 receptor agonist that exhibits altered receptor trafficking and enhanced insulinotropic responses in rodent models. Similarly, triple-agonist compounds like retatrutide incorporate glucagon receptor (GCGR) agonism alongside GIP and GLP-1 targets, offering a platform to investigate energy expenditure and hepatic lipid metabolism. In gastrointestinal tissue pathways, researchers also examine non-GLP-1 mechanisms using specialized analogues such as GLP2-T to explore intestinal mucosa preservation distinct from metabolic GLP-1 signaling. Benchmarking semaglutide against these multi-target peptides provides essential insights into pathway selectivity, receptor desensitization, and downstream gene expression.

Lyophilized Powder and Reconstituted Solution Storage Guidelines

Proper temperature control is critical to prevent chemical degradation, peptide aggregation, or moisture absorption (hygroscopicity) in lyophilized cakes. Upon receipt of a semaglutide 50mg vial from PX1 Research, store the sealed vial in a temperature-monitored freezer at -20°C for short-to-medium term storage, or -80°C for long-term archiving exceeding 12 months.

Prior to reconstitution, allow the sealed vial to equilibrate to room temperature (15°C to 25°C) inside a desiccator or sealed container. Opening a cold vial in ambient air causes atmospheric moisture to condense rapidly onto the lyophilized cake, causing localized hydrolysis and accelerating degradation.

Once reconstituted with an appropriate sterile solvent:

• Reconstituted in Bacteriostatic Water (0.9% Benzyl Alcohol): Stable at 2°C to 8°C for up to 28 days.

• Reconstituted in Unpreserved Sterile Saline or PBS: Must be used immediately or sub-aliquoted and flash-frozen at -20°C / -80°C to prevent microbial proliferation.

• Protect from Light: Store stock solutions in opaque containers or aluminum-wrapped boxes to prevent photolytic degradation of aromatic residues.

Institutional Procurement, Bulk Ordering, and Quality Guarantees

PX1 Research operates as a primary supply partner for academic institutions, biotechnology firms, and institutional research laboratories across the United States. All research compounds are synthesized in state-of-the-art GMP-compliant facilities and shipped directly from domestic distribution centers located in California and Arizona.

Orders placed before daily cutoff times Monday through Friday ship same-day, minimizing transit times and cold-chain disruption risk. Facilities requiring custom bulk fills, specific mass configurations such as 50mg vials, or formal documentation for institutional oversight can explore bulk acquisition options through the PX1 Research wholesale program or review broader mechanism documentation across our central research hub.